Literature DB >> 23775228

Metabolomics approaches for characterizing metabolic interactions between host and its commensal microbes.

Guoxiang Xie1, Shucha Zhang, Xiaojiao Zheng, Wei Jia.   

Abstract

It is increasingly evident that the gut microbiota is involved in the regulation of multiple mammalian metabolic pathways through a series of interactive host-microbiota metabolic, signaling, and immune-inflammatory axes that physiologically connect the gut, liver, brain, and other organs. Correlation of the metabotypes with the gut microbial profiles derived from culture-independent molecular techniques is increasingly useful for deciphering inherent and intimate host-microbe relationships. Real-time analysis of the small molecule metabolites derived from gut microbial-host co-metabolism is essential for understanding the metabolic functions of the gut microbiome and has tremendous implications for personalized healthcare strategies. Metabolomics, an array of analytical techniques that includes high resolution NMR spectroscopy and chromatography-MS in conjunction with chemometrics and bioinformatics tools, enables characterization of the metabolic footprints of mammalian hosts that correlate with the microbial community in the intestinal tract. The metabolomics approach provides important information of a complete spectrum of metabolites produced from the gut microbial-mammalian co-metabolism and is improving our understanding of the molecular mechanisms underlying multilevel host-microbe interactions. In this review, the interactions of gut microbiota with their host are discussed and some examples of NMR- or MS-based metabolomics applications for characterizing the metabolic footprints of gut microbial-host co-metabolism are described. Advances in the metabolomic analysis of bile acids, short-chain fatty acids, and choline metabolism are also summarized.
© 2013 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  Bile acids; Gut microbial-host co-metabolism; Metabolomics; Microbe; Short-chain fatty acids

Mesh:

Year:  2013        PMID: 23775228     DOI: 10.1002/elps.201300017

Source DB:  PubMed          Journal:  Electrophoresis        ISSN: 0173-0835            Impact factor:   3.535


  22 in total

1.  A 1H NMR metabolomic approach for the estimation of the time since death using aqueous humour: an animal model.

Authors:  Emanuela Locci; Matteo Stocchero; Antonio Noto; Alberto Chighine; Luca Natali; Pietro Emanuele Napoli; Roberto Caria; Fabio De-Giorgio; Matteo Nioi; Ernesto d'Aloja
Journal:  Metabolomics       Date:  2019-05-08       Impact factor: 4.290

2.  Pediatric Obstructive Sleep Apnea is Associated With Changes in the Oral Microbiome and Urinary Metabolomics Profile: A Pilot Study.

Authors:  Huajun Xu; Xiaoyan Li; Xiaojiao Zheng; Yunyan Xia; Yiqun Fu; Xinyi Li; Yingjun Qian; Jianyin Zou; Aihua Zhao; Jian Guan; Meizhen Gu; Hongliang Yi; Wei Jia; Shankai Yin
Journal:  J Clin Sleep Med       Date:  2018-09-15       Impact factor: 4.062

Review 3.  Cancer-promoting effects of microbial dysbiosis.

Authors:  Amy M Sheflin; Alyssa K Whitney; Tiffany L Weir
Journal:  Curr Oncol Rep       Date:  2014-10       Impact factor: 5.075

Review 4.  Complementary Methodologies To Investigate Human Gut Microbiota in Host Health, Working towards Integrative Systems Biology.

Authors:  Manuel Ferrer; David Rojo; Celia Méndez-García; Coral Barbas
Journal:  J Bacteriol       Date:  2018-01-10       Impact factor: 3.490

5.  Diel metabolomics analysis of a hot spring chlorophototrophic microbial mat leads to new hypotheses of community member metabolisms.

Authors:  Young-Mo Kim; Shane Nowack; Millie T Olsen; Eric D Becraft; Jason M Wood; Vera Thiel; Isaac Klapper; Michael Kühl; James K Fredrickson; Donald A Bryant; David M Ward; Thomas O Metz
Journal:  Front Microbiol       Date:  2015-04-17       Impact factor: 5.640

6.  Altered bile acid profile in mild cognitive impairment and Alzheimer's disease: Relationship to neuroimaging and CSF biomarkers.

Authors:  Kwangsik Nho; Alexandra Kueider-Paisley; Siamak MahmoudianDehkordi; Matthias Arnold; Shannon L Risacher; Gregory Louie; Colette Blach; Rebecca Baillie; Xianlin Han; Gabi Kastenmüller; Wei Jia; Guoxiang Xie; Shahzad Ahmad; Thomas Hankemeier; Cornelia M van Duijn; John Q Trojanowski; Leslie M Shaw; Michael W Weiner; P Murali Doraiswamy; Andrew J Saykin; Rima Kaddurah-Daouk
Journal:  Alzheimers Dement       Date:  2018-10-15       Impact factor: 16.655

Review 7.  Potential of metabolomics to reveal Burkholderia cepacia complex pathogenesis and antibiotic resistance.

Authors:  Nusrat S Shommu; Hans J Vogel; Douglas G Storey
Journal:  Front Microbiol       Date:  2015-07-13       Impact factor: 5.640

8.  Alzheimer's disease and the microbiome.

Authors:  Surjyadipta Bhattacharjee; Walter J Lukiw
Journal:  Front Cell Neurosci       Date:  2013-09-17       Impact factor: 5.505

Review 9.  Gut Microbiota and Nonalcoholic Fatty Liver Disease: Insights on Mechanism and Application of Metabolomics.

Authors:  Xuyun He; Guang Ji; Wei Jia; Houkai Li
Journal:  Int J Mol Sci       Date:  2016-03-15       Impact factor: 5.923

10.  Chemopreventive Metabolites Are Correlated with a Change in Intestinal Microbiota Measured in A-T Mice and Decreased Carcinogenesis.

Authors:  Amrita K Cheema; Irene Maier; Tyrone Dowdy; Yiwen Wang; Rajbir Singh; Paul M Ruegger; James Borneman; Albert J Fornace; Robert H Schiestl
Journal:  PLoS One       Date:  2016-04-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.